Full-Time

Lab Technician

Evening Shift

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

Compensation Overview

$18.85 - $29.62/hr

+ Short-term Incentives

Junior

Hoover, AL, USA

Category
Lab & Research
Medical Research
Requirements
  • Bachelor’s degree from an accredited college/university in a biomedical discipline (Chemical, physical, biological, clinical lab science, or medical technology) OR Associate degree from an accredited college/university in laboratory science or medical laboratory technology
  • Ability to read and follow Standard Operating Procedures (SOPs) and to maintain complete and accurate records
  • Excellent written and verbal communication skills, interpersonal skills and analytical/problem solving skills
  • Proficiency in the use of personal computers and applicable software
Responsibilities
  • Responsible for performing testing in accordance with established Standard Operating Procedures (SOPs), applicable sections of the Code of Federal Regulations (CFRs), with emphasis on Good Manufacturing Practices (GMPs), the Clinical Laboratory Improvement Act of 1988 (CLIA), and applicable Takeda and BioLife policies, procedures and quality initiatives
  • Perform only high and moderate complexity tests for which certification has been authorized by the laboratory director or designee and deemed commensurate with their education, training, and technical abilities
  • Responsible for sample management, test performance, quality control, result review, result reporting and equipment maintenance such that accurate and appropriate sample testing is performed, completed, and reported in a timely manner
  • Follow the laboratory’s procedures for specimen handling and processing, test analyses, reporting and maintaining records of donor test results
  • Test and maintain records that demonstrate proficiency testing samples are tested in the same manner as donor samples
  • Adhere to the laboratory’s quality control policies, document all quality control activities, instrument and procedural calibrations and maintenance performed
  • Identify problems that may adversely affect test performance or reporting of test results and either correct the problems or immediately notify the laboratory management
  • Follow the laboratory’s established corrective action policies and procedures whenever test systems are not within the laboratory’s established acceptable levels of performance
  • Document all corrective actions taken when test systems deviate from the laboratories established performance specifications
  • Participate in operational excellence initiatives and projects to drive a culture of continuous improvement to achieve site operational excellence goals (including but not limited to 5S, Value Stream Mapping and Kaizen)
  • Other duties as assigned
Desired Qualifications
  • Bachelor’s degree in medical technology or Associates degree in medical laboratory technology
  • 1-year laboratory training or work experience preferred
  • MT or MLT certification from ASCP or other accredited certifying organization preferred

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, with plans for up to 15 product launches by FY2024. Takeda's products are aimed at healthcare providers, hospitals, and patients around the world, and the company collaborates with about 41,000 suppliers to support its operations. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that the needs of patients guide its work. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and human health. The company's goal is to innovate and provide life-changing treatments while also promoting a healthier planet.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.